Skip to main content
. Author manuscript; available in PMC: 2017 Aug 3.
Published in final edited form as: Biochim Biophys Acta. 2016 Apr 19;1861(7):630–638. doi: 10.1016/j.bbalip.2016.04.013

Table 1. Clinical characteristics of study subjects.

cirrhosis
control compensated decompensated
n 20 59 21
Age (y) 67 (66-69) 58 (53-64) 58 (50-66)
Male/female 15/5 42/17 16/5
Total cholesterol (mg/dL) 169 (152-188) 173 (134-209) 86 (64-123)***††
Triglycerides (mg/dL) 103 (70-145) 81 (60-105) 77 (62-123)
LDL-cholesterol (mg/dL) 78 (60-102) 107 (72-133) 63 (42-74)††
HDL-cholesterol (mg/dL) 65 (55-80) 44 (25-61)* 10 (6-19)***††
Apolipoprotein A-I (mg/dL) 79 (57-113) 37 (27-52)*** 17 (15-24)***†
CRP (mg/L) 2 (1-3) 3 (1-5) 25 (12-46)***††
Child-Pugh Score - 5 (5-6) 10 (8-12)
MELD Score - 10 (8-14) 17 (15-19)
Etiology of liver disease (%)
Alcohol - 49.1 95.2
Viral infection - 21.1 4.8
Other - 29.8 -
Albumin$ (g/dL) - 4.0 ± 0.6 2.9 ± 0.7
Bilirubin$ (mg/dL) - 1.7 ± 1.6 5.3 ± 4.7
Creatinine$ (mg/dL) 0.9 ± 0.3 0.9 ± 0.2 1.0 ± 0.6

Values are given as medians with the interquartile range. $Values are given as mean ± SD. CRP, C-reactive protein. *P < 0.05, ***P < 0.001 vs. control. P < 0.01, ††P < 0.001 vs. compensated.